Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine in maintenance hemodialysis patients
NCT05673239Phase 4Completed
- Sponsor
- First Affiliated Hospital, Zhejiang University School of Medicine
- Start
- Jan 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of levocarnitine in carnitine deficiency, sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoint: Left ventricular ejection fraction at 12 weeks. Started Jan 2023; status: completed.
02
Drugs
levocarnitine
03
Conditions
carnitine deficiency
Beyond the preview
Go deeper on NCT05673239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05673239.